Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bennett C. Meier"'
Autor:
Daniel E. Neafsey, Dyann F. Wirth, Jon Clardy, Arvind Sharma, Ping S. Lui, Anne-Marie Zeeman, Sean Eckley, Yvonne Van Gessel, Mathias Wawer, Matthias Marti, Elizabeth A. Winzeler, Elamaran Meibalan, Nobutaka Kato, Benito Munoz, Emily R. Derbyshire, Stuart L. Schreiber, Marshall L. Morningstar, Jeremy R. Duvall, Clemens H. M. Kocken, Eli L. Moss, Bennett C. Meier, Joshua A. Bittker, Vicky M. Avery, Manmohan Sharma, John E. Burke, Eamon Comer, Jacob A. McPhail, Maurice A. Itoe, Jessica Bastien, Nicolas M. B. Brancucci, Branko Mitasev, David Clarke, Timothy A. Lewis, Victoria C. Corey, Sandra Duffy, Tomoyo Sakata-Kato, Fabian Gusovsky, Sandra March, Takashi Yoshinaga, Gillian L. Dornan, Flaminia Catteruccia, Morgane Sayes, Emily Lund, Christina Scherer, Sangeeta N. Bhatia, Michael Foley, Amit Sharma, Amanda K. Lukens, Paul A. Clemons, Koen J. Dechering, Karin M. J. Koolen, Micah Maetani
Publikováno v:
Nature
Antimalarial drugs have thus far been chiefly derived from two sources-natural products and synthetic drug-like compounds. Here we investigate whether antimalarial agents with novel mechanisms of action could be discovered using a diverse collection
Autor:
Florence F. Wagner, Deepika Walpita, Jennifer P. Gale, Noel G. Morgan, Bennett C. Meier, Shrikanta Chattopadhyay, Thomas Mandrup-Poulsen, Tamara J. Gilbert, Amedeo Vetere, Jacob M. Hooker, Taner Kaya, Mélanie Leroy, Sarah J. Richardson, Edward B. Holson, Yan-Ling Zhang, Morten Lundh, Stewart L. Fisher, Thomas Galbo, Patrick McCarren, Bridget K. Wagner, Dan Ploug Christensen
Publikováno v:
ACS Chemical Biology. 11:363-374
Modulation of histone deacetylase (HDAC) activity has been implicated as a potential therapeutic strategy for multiple diseases. However, it has been difficult to dissect the role of individual HDACs due to a lack of selective small-molecule inhibito
Autor:
Bennett C. Meier, Bridget K. Wagner
Publikováno v:
Epigenomics. 6:209-214
Modulation of histone deacetylase (HDAC) activity has been implicated as a potential therapeutic strategy for multiple diseases. Recent studies have put a greater spotlight on metabolic diseases, in particular Type 1 and Type 2 diabetes, as potential
Autor:
Ercument Dirice, Vlado Dančík, Sevim Kahraman, David E. Olson, Tamara J. Gilbert, Amedeo Vetere, Bennett C. Meier, Sean M. Burns, Bridget K. Wagner, Rohit N. Kulkarni, Deepika Walpita, Jiang Hu, Paul A. Clemons
Publikováno v:
Diabetes
Restoring functional β-cell mass is an important therapeutic goal for both type 1 and type 2 diabetes (1). While proliferation of existing β-cells is the primary means of β-cell replacement in rodents (2), it is unclear whether a similar principle